Galway, Ireland, Dec 5- AOTI, Ltd., announced today that Pro2Med Inc. has been appointed its exclusive distributor in the USA for its TWO2 wound care product line.
“We are extremely pleased to have signed this exclusive agreement with Pro2Med. They have a team of seasoned and well respected sales professionals with many years of experience selling medical devices”, stated Mike Griffiths, CEO of AOTI, “and will be able to provide the level of customer service and support our customers expect.”
AOTI is founded on a decade of experience in providing innovative solutions to resolve severe and chronic wounds worldwide. Our products reduce healthcare costs and improve the quality of life for patients with these debilitating illnesses. Our patented non-invasive Topical Wound Oxygen (two2) therapy is unsurpassed in fully closings Diabetic, Venous and Pressure ulcers alike. AOTI is a private company based in Galway, Ireland with offices throughout the globe. For more information, see www.aotinc.net.